Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Tranexamic Acid in ACL Reconstruction
NCT03631355Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in hemarthrosis, sponsored by NYU Langone Health. Started Jun 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemarthrosis
Beyond the preview
Go deeper on NCT03631355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03631355.